In 2018, Diabetes UK reported that over 1 million people in the UK relied on insulin to manage their diabetes.1
Insulin is a high-risk medication and, with the launch of different insulin concentrations and biosimilar insulins, it is crucial for all healthcare practitioners involved in prescribing, preparing or administering insulin to possess the knowledge and competency to do so safely.
Updated in 2022, this quick guide reviews the steps that should be taken to reduce the risks involved in the prescribing, preparation and administration of insulin.
Readers are directed to the PDF version of this article.
SGLT2 inhibitors show greater cardiovascular effects in older versus young people, whilst GLP-1 RAs are more effective in younger people.
1 May 2025